Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
United Therapeutics Corp
NASDAQ:UTHR
United Therapeutics Corp
NASDAQ:UTHR
Price:
595.315
USD
1.51%
Market Closed
Market Cap:
$25.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
D
|
Danel Adir Yeoshua Ltd
TASE:DANE
|
IL |
|
BJ's Wholesale Club Holdings Inc
NYSE:BJ
|
US |
|
Full Truck Alliance Co Ltd
NYSE:YMM
|
CN |
|
P
|
Pan American Silver Corp
F:PA2
|
CA |
|
S
|
Sun Hung Kai Properties Ltd
XMUN:SHG
|
HK |
|
P
|
PVH Corp
XMUN:PVH
|
US |
|
P
|
Perdoceo Education Corp
F:CE1
|
US |
|
ING Bank Slaski SA
F:6GF
|
PL |
|
B
|
Babcock International Group PLC
DUS:BW3
|
UK |
Wall St Price Targets
UTHR Price Forecast
Based on 18 analysts
Based on 18 analysts
+19% Upside
from
$595.315
today
United Therapeutics Corp (UTHR)’s 12-month stock price forecast through October 2027 has a consensus target of $706.35, implying 19% upside. The forecast is based on price targets from 18 Wall Street analysts.
UTHR Analyst Rating
Based on 15 analysts
Based on 15 analysts
Analysts rate UTHR Buy, with 11 of 15 recommending Buy or Strong buy.
United Therapeutics Corp Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTHR's stock price target?
Price Target
706.35
USD
706.35
USD
According to Wall Street analysts, the average 1-year price target for UTHR is 706.35 USD with a low forecast of 371.68 USD and a high forecast of 764.4 USD.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for United Therapeutics Corp?
Projected CAGR
15%
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.
What is the Pre-Tax Income forecast for United Therapeutics Corp?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.